Literature DB >> 25516474

Similarities and differences between pediatric and adult patients with systemic lupus erythematosus.

T Tarr1, B Dérfalvi2, N Győri1, A Szántó1, Z Siminszky1, A Malik3, A J Szabó3, G Szegedi1, M Zeher4.   

Abstract

Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease with highest prevalence among women of childbearing age. However, children younger than 16 years also can develop SLE (childhood-onset lupus/juvenile-type SLE). The aim of our study was to compare the clinical course of adult and pediatric-onset SLE. Data from 342 adult patients followed at the University of Debrecen, Hungary, and 79 children documented in the Hungarian National Pediatric SLE registry were analyzed using hospital medical records. Organ manifestations, laboratory parameters, and immunoserological characteristics were reviewed and the results were evaluated using SPSS for Windows software.Gender distribution was not significantly different between groups with disease starting in childhood vs adulthood. The prevalence of the following manifestations was significantly higher for pediatric than for adult-onset disease including: lupus nephritis (43% pediatric vs 26.4% for adult-onset), hematological disorders (57% vs 36.4%), photosensitivity (20% vs 9%), butterfly rash (61% vs 35.5%) and mucosal ulceration (11.4% vs 4%). For adult-onset SLE, neurological symptoms (30% vs 6%) and polyarthritis (86% vs 68%) occurred significantly more frequently than in children. Anti-SSA, anti-SSB and antiphospholipid antibodies were detected at significantly higher levels in adult-onset patients compared to those in pediatrics. Children were more commonly given high-dose intravenous immunoglobulin treatment (6.3% vs 0.6%) and mycophenolate mofetil (15.2% vs 5.3%) than adults.These results suggest that pediatric and adult-onset SLE differ in multiple aspects, and it is important to recognize these differences for optimal treatment and prognosis of these patients.
© The Author(s) 2014.

Entities:  

Keywords:  SLE; adult; differences; pediatric; similarities

Mesh:

Substances:

Year:  2014        PMID: 25516474     DOI: 10.1177/0961203314563817

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  24 in total

Review 1.  Advances in the care of children with lupus nephritis.

Authors:  Scott E Wenderfer; Natasha M Ruth; Hermine I Brunner
Journal:  Pediatr Res       Date:  2016-11-17       Impact factor: 3.756

2.  Prospective validation of a novel renal activity index of lupus nephritis.

Authors:  G Gulati; M R Bennett; K Abulaban; H Song; X Zhang; Q Ma; S V Brodsky; T Nadasdy; C Haffner; K Wiley; S P Ardoin; P Devarajan; J Ying; B H Rovin; H I Brunner
Journal:  Lupus       Date:  2016-12-19       Impact factor: 2.911

3.  Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality.

Authors:  Alimohammad Fatemi; Mohammad Matinfar; Abbas Smiley
Journal:  Clin Rheumatol       Date:  2016-12-23       Impact factor: 2.980

4.  Self-management and adherence in childhood-onset systemic lupus erythematosus: what are we missing?

Authors:  O Harry; L E Crosby; A W Smith; L Favier; N Aljaberi; T V Ting; J L Huggins; A C Modi
Journal:  Lupus       Date:  2019-03-24       Impact factor: 2.911

5.  Gastrointestinal system manifestations in juvenile systemic lupus erythematosus.

Authors:  Hafize Emine Sönmez; Asuman Nur Karhan; Ezgi Deniz Batu; Yelda Bilginer; Ersin Gümüş; Hülya Demir; Aysel Yüce; Seza Özen
Journal:  Clin Rheumatol       Date:  2017-02-16       Impact factor: 2.980

6.  Spectrum of systemic lupus erythematosus in Oman: from childhood to adulthood.

Authors:  Asma Al Rasbi; Eiman Abdalla; Rabab Sultan; Nasreen Abdullah; Juma Al Kaabi; Ibrahim Al-Zakwani; Reem Abdwani
Journal:  Rheumatol Int       Date:  2018-05-02       Impact factor: 2.631

7.  Characterization of chronic arthritis in a multicenter study of 852 childhood-onset systemic lupus erythematosus patients.

Authors:  Ana Paula Sakamoto; Clovis Artur Silva; Mariana Paes Leme Ferriani; Rosa Maria Rodrigues Pereira; Eloisa Bonfá; Claudia Saad-Magalhães; Eunice Okuda; Simone Appenzeller; Francisco Hugo Gomes; Ana Luiza Garcia Cunha; Mirna Henriques Tomich Salume; Daniela Petry Piotto; Maria Teresa Terreri
Journal:  Rheumatol Int       Date:  2016-09-14       Impact factor: 2.631

8.  Chronic arthritis in systemic lupus erythematosus: distinct features in 336 paediatric and 1830 adult patients.

Authors:  Natali W S Gormezano; Clovis A Silva; Nadia E Aikawa; Diego L Barros; Mariana A da Silva; Carini I Otsuzi; Katia Kozu; Luciana Parente Seguro; Rosa M R Pereira; Eloisa Bonfá
Journal:  Clin Rheumatol       Date:  2015-11-28       Impact factor: 2.980

9.  Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.

Authors:  Chen-Xing Zhang; Li Cai; Kang Shao; Jing Wu; Wei Zhou; Lan-Fang Cao; Tong-Xin Chen
Journal:  Pediatr Nephrol       Date:  2017-12-20       Impact factor: 3.714

10.  Impact of autoimmune cytopenias on severity of childhood-onset systemic lupus erythematosus: A single-center retrospective cohort study.

Authors:  Ekemini A Ogbu; Shanmuganathan Chandrakasan; Kelly Rouster-Stevens; Larry A Greenbaum; Ignacio Sanz; Scott E Gillespie; Chelsea Marion; Karli Okeson; Sampath Prahalad
Journal:  Lupus       Date:  2020-10-27       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.